BioSante Pharmaceuticals (Nasdaq : BPAX) $1.71. Today announed positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Gleevec (imatinib mesylate). All patients enrolled in the trial used Gleevec for at least one year and still had cancer cells present. The study was conducted by researchers at the Johns Hopkins Kimmel Cancer Center in Baltimore, Maryland, led by Hyam Levitsky, M.D., professor of oncology, medicine and urology at the Cancer Center. The research was funded by the National Institutes of Health.
In a study published in Clinical Cancer Research, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center investigators used a vaccine made from CML cells irradiated to halt their cancerous potential and genetically altered to produce an immune system stimulator called GM-CSF. The treated cells also carry molecules, called antigens, specific to CML cells, which prime the immune system to recognize and kill circulating CML cells.
What They Do: BioSante is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism.
Force Protection (Nasdaq: FRPT) $6.54. Today announced it has received a modification to contract M67854-07-D-5031 from the United States Marine Corps Systems Command for additional field service support. The contract modification extends the ongoing performance of 216 field service representatives and associated support for Independent Suspension System (ISS) installations for Cougars at the MRAP Sustainment Facility (MSF) in Kuwait. The modification has a firm fixed price value of $26.1 million. Work is expected to be completed by June 2010.
What They Do: Force Protection, Inc. is a leading designer, developer and manufacturer of survivability solutions, including blast- and ballistic-protected wheeled vehicles currently deployed by the U.S. military and its allies to support armed forces and security personnel in conflict zones.
The U.S. Renewable Energy Group, A-Power Energy Generation Systems, (Nasdaq: APWR) $12.52, and American Nevada Group today announced the development and construction of a new production and assembly plant in Nevada that will supply highly advanced wind energy turbines to renewable energy projects throughout North and South America. The state-of-the-art facility will be approximately 320,000 square feet with annual production capacity of 1,100 megawatts of wind energy turbines annually, enough to power 330,000 homes. The facility is expected to employ approximately 1,000 Nevada workers and create even more jobs during the construction process. ANC will identify potential sites for the facility and will develop the facility for the group.
What They Do: A-Power Energy Generation Systems Ltd. ("A-Power"), through its China-based operating subsidiaries, is the largest provider of distributed power generation systems in, focusing on energy-efficient and environmentally friendly projects of 25MW to 400MW.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit http://www.smallcapreview.com/. To follow us on Twitter visit http://twitter.com/SmallCapReview.
